GlycoMimetics Quote - GLYC

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.2972

Bid

0.2972

Ask

0.3002

Volume

481,222

0.00 Day's Range 0.00

0.235 52 Week Range 3.5299

Market Cap

21.273M

Previous Close

0.334

Open

Last Trade

100

0.2972

(formt)

Last Trade Time

05:22:21

Financial Volume

VWAP

Average Volume (3m)

4,362,917

Shares Outstanding

64,464,412

Dividend Yield

PE Ratio

-0.58

Earnings Per Share (EPS)

-0.57

Revenue

10k

Net Profit

-36.9M

GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbo... GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.glycomimetics.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

GlycoMimetics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GLYC. The last closing price for GlycoMimetics was US$0.33. Over the last year, GlycoMimetics shares have traded in a share price range of US$ 0.235 to US$ 3.5299.

GlycoMimetics currently has 64,464,412 shares outstanding. The market capitalization of GlycoMimetics is US$21.27 million. GlycoMimetics has a price to earnings ratio (PE ratio) of -0.58.

Form 8-K - Current report

GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Company exploring path forward for uproleselan in multiple AML settings based on observed efficacy results, including clinically meaningful results in primary refractory AML, and significant...

GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024

GlycoMimetics, Inc. (Nasdaq: GLYC) a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced that...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population Adverse events were consistent with known side effect...

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.052	21.207177814	0.2452	0.438	0.235	36779269	0.32199975	CS
4	0.0272	10.0740740741	0.27	0.438	0.235	8425225	0.31773919	CS
12	-2.7028	-90.0933333333	3	3.02	0.235	4362917	0.44547742	CS
26	-2.2628	-88.390625	2.56	3.5299	0.235	2216237	0.66414443	CS
52	-1.5528	-83.9351351351	1.85	3.5299	0.235	1173039	0.72173198	CS
156	-2.2428	-88.2992125984	2.54	4.16	0.235	704105	1.28413153	CS
260	-11.1928	-97.4134029591	11.49	13.41	0.235	657554	2.18857936	CS

Symbol	Price	Vol.
AXISAxis Auto Finance Inc	$ 0.045 (28.57%)	1,000
NCFNorthcliff Resources Ltd	$ 0.025 (25.00%)	10k
AMMAlmaden Minerals Ltd New	$ 0.105 (23.53%)	154.73k
GFPGreenFirst Forest Products Inc	$ 0.40 (21.21%)	382.15k
AVCNAvicanna Inc	$ 0.35 (18.64%)	437.61k
VGCXVictoria Gold Corp	$ 1.36 (-81.70%)	61.51k
SCYScandium International Mining Corp	$ 0.015 (-40.00%)	19k
DNDelta 9 Cannabis Inc	$ 0.01 (-33.33%)	2.01M
NCPNickel Creek Platinum Corp	$ 0.015 (-25.00%)	38.72k
SMCSulliden Mining Capital Inc	$ 0.015 (-25.00%)	612.1k
TRPTC Energy Corporation	$ 53.49 (0.19%)	20.76M
FCUFission Uranium Corp	$ 1.17 (-1.68%)	8.51M
CNQCanadian Natural Resources Ltd	$ 48.38 (-0.72%)	6.87M
MFCManulife Financial Corporation	$ 36.16 (1.03%)	6.49M
BTEBaytex Energy Corp	$ 4.68 (-0.21%)	4.87M

Symbol

Price

Vol.